The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
基本信息
- 批准号:8652710
- 负责人:
- 金额:$ 32.24万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-05 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAdenocarcinomaAffinityAnteriorAntibioticsAntralBacteriaBindingBiochemicalBiological AssayCellsChemicalsChemoreceptorsChemotaxisConfocal MicroscopyCuesDataDiseaseDisease OutcomeDrug or chemical Tissue DistributionDuodenal UlcerEngineeringEnvironmentEpithelialEpithelial CellsEpitheliumGastric GlandsGastric Parietal CellsGastritisHabitatsHelicobacter InfectionsHelicobacter pyloriHumanImpairmentIndividualInfectionKnowledgeLeadLigandsMalignant NeoplasmsMeasuresMediatingMedicalMethodsMicrobial BiofilmsMovementMucous MembraneMusOrganPathogenesisPatternPerceptionPeriplasmic Binding ProteinsPopulationPropertyProteinsResearch PersonnelResolutionRoleSignal TransductionStomachStomach DiseasesStructureSurfaceSystemTestingTropismUlcerUreaVAI-2basecell motilitydensitydesignin vivo Modelinsightmonolayermutantnext generationnovelpathogenperiplasmpreventpublic health relevancequorum sensingreceptorresponsestructural biology
项目摘要
PROJECT SUMMARY
Helicobacter pylori is a human gastric pathogen that colonizes half the world's population and causes a wide
range of diseases including gastritis, ulcers, and cancer. The distribution of the bacteria in the stomach is
correlated with disease outcomes, but the factors that determine this distribution are unknown. We hypothesize
that chemotaxis, the ability of bacteria to sense and orient their movement in response to chemical gradients in
their environment, is a key determinant of H. pylori distribution in the stomach. H. pylori is ideally suited for
testing the role of bacterial chemotaxis in tissue distribution, because it has a simple chemotaxis system with
only three core chemoreceptors and it colonizes an organ with extreme chemical gradients. This proposal
builds on our novel insights into the ligands and sensing mechanisms of H. pylori chemoreceptors. In this
proposal, we will use structural, biophysical, and biochemical approaches to understand the precise
mechanisms by which H. pylori chemoreceptors sense three key chemicals that define three important axes in
the stomach environment: urea (secreted from the gastric epithelium, defining the epithelial to luminal axis), the
bacterial-produced quorum sensing molecule autoinducer-2 (defining regions of high bacterial density in the
gastric glands versus the overlying mucosa), and acid (produced by the parietal cells in the anterior corpus
region, defining the corpus to antrum, as well as the epithelial to luminal axis in the corpus). We have
engineered mutant H. pylori that are specifically defective in sensing one of these three chemicals and we
have developed highly sensitive assays for quantifying H. pylori chemotactic responses. We will use these
existing mutants, and others that we engineer based on our new insights into the chemosensing mechanisms,
to understand how H. pylori cells organize themselves in response to chemical signals on cultured epithelial
monolayers and during infection of the mouse stomach. Knowledge gained from these studies will lead to new
strategies for preventing and treating H. pylori infections by altering the bacteria's distribution in the stomach.
More generally, these studies will provide novel insights into how bacterial pathogens perceive and navigate
the host environment, knowledge which will be crucial for designing the next generation of antibiotics that
specifically target within-host properties of bacterial invaders.
项目总结
幽门螺杆菌是一种人类胃部病原体,占世界人口的一半,并引起广泛的
一系列疾病,包括胃炎、溃疡和癌症。细菌在胃中的分布是
与疾病结果相关,但决定这种分布的因素尚不清楚。我们假设
这种趋化性,即细菌感知和定位自己的运动以响应化学梯度的能力
他们所处的环境是幽门螺杆菌在胃中分布的关键决定因素。幽门螺杆菌非常适合于
测试细菌趋化性在组织分布中的作用,因为它有一个简单的趋化性系统,
只有三个核心化学感受器,它定植在一个具有极端化学梯度的器官上。这项建议
建立在我们对幽门螺杆菌化学受体的配体和传感机制的新见解的基础上。在这
提案,我们将使用结构、生物物理和生化方法来了解
幽门螺杆菌化学感受器感知三种关键化学物质的机制
胃环境:尿素(由胃上皮分泌,定义上皮到管腔轴),
细菌产生的群体感应分子自动诱导剂-2(定义细菌密度高的区域
胃腺与上覆粘膜)和酸(由前体壁细胞产生)
区域,定义体部至胃窦,以及体部的上皮轴至管腔轴)。我们有
幽门螺杆菌的工程突变株在感知这三种化学物质中的一种方面存在明显缺陷,而我们
已经开发出高度灵敏的方法来量化幽门螺杆菌的趋化反应。我们将使用这些
现有的突变体,以及我们基于对化学传感机制的新见解而设计的其他突变体,
了解幽门螺杆菌细胞如何在培养的上皮细胞上对化学信号作出反应
在小鼠胃单分子层和感染期间。从这些研究中获得的知识将导致新的
通过改变幽门螺杆菌在胃中的分布来预防和治疗幽门螺杆菌感染的策略。
更广泛地说,这些研究将为细菌病原体如何感知和导航提供新的见解
宿主环境,对设计下一代抗生素至关重要的知识,
特别针对细菌入侵者的宿主内特性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Karen J Guillemin其他文献
Karen J Guillemin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Karen J Guillemin', 18)}}的其他基金
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10227108 - 财政年份:2018
- 资助金额:
$ 32.24万 - 项目类别:
Engineering microbiota to optimize population-level health
工程微生物群以优化人群健康
- 批准号:
10468041 - 财政年份:2018
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8997473 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9318540 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
8629573 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
The Role of Chemotaxis in Helicobacter pylori Distribution in the Host
趋化性在幽门螺杆菌在宿主体内分布中的作用
- 批准号:
9118193 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
A Zebrafish Model to Study the Role of the Microbiota in the Etiology of Intestin
研究微生物群在肠病因学中的作用的斑马鱼模型
- 批准号:
9207745 - 财政年份:2014
- 资助金额:
$ 32.24万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 32.24万 - 项目类别: